Prevalence of hemolytic neonatal hyperbilirubinemia (NHB) is not well characterized, and economic burden at the population level is poorly understood. This study evaluated the prevalence, clinical characteristics, and economic burden of hemolytic NHB newborns receiving treatment in . real-world settings. | Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States